Bio Rad Laboratories Inc (BIO) Files Form 4 Insider Selling : Shannon Hall Sells 1,572 Shares

Bio Rad Laboratories Inc (BIO): Shannon Hall , Executive Vice President of Bio Rad Laboratories Inc sold 1,572 shares on Jun 13, 2016. The Insider selling transaction was reported by the company on Jun 14, 2016 to the Securities and Exchange Commission. The shares were sold at $145.30 per share for a total value of $228,460.86 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 13, 2016, Alice N Schwartz (director 10% owner) sold 7,000 shares at $147.02 per share price.On Mar 14, 2016, Christine A Tsingos (EVP and CFO) sold 6,630 shares at $137.81 per share price.Also, On Dec 15, 2015, Shawn Marie Soderberg (EVP, General Counsel, Sec) sold 1,900 shares at $135.50 per share price.On Nov 20, 2015, Giovanni Magni (EVP, Chief Strategy Officer) sold 6,000 shares at $140.00 per share price.

Shares of Bio-Rad Laboratories (BIO) ended Friday, Jun 10, 2016 session in red amid volatile trading. The shares closed down -2.06 points or -1.39% at $146.58 with 54,513 shares getting traded. Post opening the session at $148.03, the shares hit an intraday low of $146.35 and an intraday high of $149.96 and the price vacillated in this range throughout the day. The company has a market cap of $4,309 M and the number of outstanding shares has been calculated to be 2,93,97,359 shares. The 52-week high of Bio-Rad Laboratories is $152.38 and the 52-week low is $122.03.

Bio-Rad Laboratories Money Flow Index Chart

Bio-Rad Laboratories Inc. (Bio-Rad) manufactures and supplies products and systems used for the life science research healthcare analytical chemistry and other markets. The Company offers products to separate complex chemical and biological materials and to identify analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company’s Life Science segment develops manufactures and markets a range of over 5000 reagents apparatus and laboratory instruments. The Company’s Clinical Diagnostics segment designs manufactures sells and supports test systems informatics systems test kits and quality controls that serve clinical laboratories in the global diagnostics market. Bio-Rad’s product brands include Droplet Digital and BioPlex. As of December 31 2014 the Company had direct distribution channels in over 35 countries outside the United States through subsidiaries.

Leave a Reply

Bio-Rad Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Bio-Rad Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.